About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
X
LinkedIn
Contact Us

The Latest

Newsroom

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Recent Posts

4/24/2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
2/27/2024
BigHat’s CIO on Software Engineering Daily podcast
Announcements
12/5/2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
10/26/2023
BigHat on Genetic Engineering & Biotechnology News
Press
8/2/2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6/8/2023
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023
Presentations
6/1/2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12/21/2022
BigHat Year in Review 2022
Announcements
11/29/2022
BigHat Biosciences Announces Research Collaboration with Merck
Announcements
9/29/2022
BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit
Announcements
7/20/2022
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
Announcements
6/23/2022
BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco
Announcements
Contact
1900 Alameda de las Pulgas
Suite 400
San Mateo, CA 94403
Navigation
About
Platform
Therapeutics
Partnering
Careers
Newsroom
Publications
Social
X
LinkedIn
© BigHat Bio 2026